Op Marketingfacts delen NIMA Register Marketeers hun mening over vakliteratuur. Welke boeken zijn interessant of relevant en wat vinden ervaren marketingprofessionals ervan? We recenseren de meest uiteenlopende...
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by Roche and Genentech’s Herceptin (trastuzumab) with the announcement that their own biosimilar version of...
GlaxoSmithKline and Sanofi have joined academic groups and other pharma companies to take part in Finland’s large scale genomics project, based on data from 500,000 biobank volunteers.
U.S. drugmaker Biogen rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.
Takeda’s surprise announcement that it was weighing up a move for Shire had some analysts sceptical about whether the Japanese company could pull off such a larger acquisition.
Misha Stoutenbeek is marketingadviseur en copywriter. Hij beschouwt in zijn blogs alledaagse marketingpraktijken. In deze aflevering wordt hij geconfronteerd met een merk zonder menselijke kant, marketing zonder passie.
The old adage “better late than never” may be overused, but for Celgene, it certainly applies to England’s cost watchdogs and their stance toward the company’s multiple myeloma flagship drug Revlimid.
Digital audio Mediabrands en Spotify organiseerden een Digital Audio seminar waarin alle ins en outs van dit opkomende medium onder de loep werden genomen. Tess Zwaagstra, AV Consultant Mediabrands en Amber Verburg...
To investigate potential alternative treatment strategies for patients with hypothyroidism, researchers have now for the first time succeeded in generating thyroid mini-organs in the lab. In a new study published in...
Cushing’s disease Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy and safety of Isturisa (osilodrostat), for the treatment of Cushing’s...
We gebruiken cookies om ervoor te zorgen dat onze website zo soepel mogelijk draait. Als u doorgaat met het gebruiken van de website, gaan we er vanuit dat u ermee instemt.